Skip to content
InternetData
AS33759

Regeneron Pharmaceuticals Inc.

AS33759 is Regeneron Pharmaceuticals Inc. (regeneron.com). It announces 512 IPv4 addresses in 2 prefixes, and 0 IPv6 prefixes.

United States· ARIN· allocated 2012-12-11· business

512
IPv4 addresses announced
2
IPv4 prefixes
0
IPv6 prefixes
100.00%
of its routes RPKI-valid
512
of its IPv4 geolocated
1
country

Where its space is

The IPv4 it announces that IP Geolocation places, by country. A /24 counts for the AS announcing most of it.

  1. United States512 · 100.00%

Registry record

Its ASN Whois record, as the registry publishes it.

handle
REGENERON
name
Regeneron Pharmaceuticals Inc.
org
RP-30
org name
Regeneron Pharmaceuticals Inc.
org address
777 Old Saw Mill River Rd., Tarrytown, NY, 10591
org city
Tarrytown
org country
US
country
US
source
arin
created
2012-12-11
updated
2012-12-11
remarks
http://www.regeneron.com
abuse name
Michael Phillips
abuse phone
+1-914-847-7000
abuse kind
person
abuse city
Tarrytown
abuse country
US
admin name
Michael Phillips
admin phone
+1-914-847-7000
admin kind
person
admin city
Tarrytown
admin country
US
tech name
Michael Phillips
tech phone
+1-914-847-7000
tech kind
person
tech city
Tarrytown
tech country
US
abuse validated
1

What the databases see

Addresses each address-keyed database holds in the IPv4 it announces, as a share of that space, with its largest providers. Counts overlap.

IPv4 prefixes

Every IPv4 prefix BGP Route saw it announce. A prefix another AS also announces says so.

2 prefixes
PREFIXCOUNTRYRPKIPEERSFIRST SEEN
24.38.10.0/24United Statesvalid162026-10-02
72.43.219.0/24United Statesvalid172026-10-02
00 · Evaluate

Test the real build first.

An evaluation license puts a full current build in your hands, with no sampling, so you can measure it against your own traffic before anyone talks about terms.

01 · License

Then license what you use.

Standard, for detection and decisions inside your own product and operations.
Redistribution, when the data ships onward inside what you sell, priced by scope rather than by seat.
Annual terms, a named contact, and monthly, quarterly or yearly payment.